Abstract: A dynamic support system mounted to a chair to permit a user to be supported in one of a plurality of positions is provided. The dynamic support system includes a seat assembly coupled to the chair and having a cushion and a pair of support plate assemblies coupled to the cushion, each support plate assembly having a central interface plate coupled to the chair and disposed between an inner interface plate and an outer interface plate, the central interface plate of each support plate assembly having a pair of pivot slots, the inner and outer interface plates of each support plate assembly coupled to the cushion by a pair of bolts extending through the inner interface plate, the pair of pivot slots in the central interface plate and the outer interface plate of each support plate assembly. The seat assembly can adjust between an anterior position and a posterior position.

Abstract: The remote collection of data for the account of an entity (2) uses a data communications network (26) operated by a third party (28) with respect to the entity. It is characterised in that the access to said data communication network (26) by the entity for remote data collection is governed dynamically by said third party (28) as a function of the spare data-carrying capacity of the communications network. The third party (28) may thus grant the entity (2) access to the communications network (26) when the level of the third party's own data traffic on said network is below a determined threshold value, corresponding to an occupation below peak capacity. The approach finds applications notably in the field of automatic meter reading (AMR), where the network operator, e.g. a cellular telephone operator, is a third party with respect to the utilities company (2), and the collected data is meter reading data from remote meters (14a-14g) sent via GPRS interfaces (16a-16d).

Abstract: There is provided a fungicidal concentrate comprising azoxystrobin and propiconazole, wherein the concentrate is a suspoemulsion having an aqueous phase, an oil phase and particles dispersed in the aqueous and/or oil phase. Also provided is a method of using the compositions for combating and/or preventing fungal diseases in crops of useful plants.

Abstract: The remote collection of data for the account of an entity (2) uses a data communications network (26) operated by a third party (28) with respect to the entity. It is characterised in that the access to said data communication network (26) by the entity for remote data collection is governed dynamically by said third party (28) as a function of the spare data-carrying capacity of the communications network. The third party (28) may thus grant the entity (2) access to the communications network (26) when the level of the third party's own data traffic on said network is below a determined threshold value, corresponding to an occupation below peak capacity. The approach finds applications notably in the field of automatic meter reading (AMR), where the network operator, e.g. a cellular telephone operator, is a third party with respect to the utilities company (2), and the collected data is meter reading data from remote meters (14a-14g) sent via GPRS interfaces (16a-16d).

Abstract: An aryl sulphur compound of formula (I) : ##STR1## where R.sup.1 is C.sub.1-4 alkyl; Ar is a phenyl group optionally substituted by halogen or C.sub.1-4 alkyl and wherein Z is S or SO, having antiallergy activity.

Abstract: 1,2,3-triazoles and 1,2,4-triazoles having an N-substituted acylamino substituent are prepared by alkylating N-unsubstituted acylamino triazoles or acylating N-substituted amino triazoles. The N-substituted acylamino triazoles are useful as anti-allergy drugs. Pharmaceutical formulations containing acylamino triazoles and a method of treating allergic conditions utilizing such compounds are provided.

Abstract: Phthalimidopiperidines of the formula ##STR1## are described where R.sub.1 is hydrogen, lower alkyl, cycloalkyl of 5 to 7 carbon atoms, phenyl(lower)alkyl, pyridyl(lower)alkyl, furyl(lower)alkyl or thienyl(lower)alkyl and R.sub.2 and R.sub.3 are hydrogen or various substituents. The compounds are useful pharmaceutically, particularly as anti-convulsants, and also in some cases as anti-arrhythmic agents and anti-inflammatory agents, and in some cases useful as intermediates for the preparation of 4-aminoquinoline derivatives having anti-malarial activity.

Abstract: 3-(7-Halo-4-quinolyl)-N-[di(loweralkyl)amino(lower alkyl)]-N-(lower alkyl)benzamides and 4-(7-halo-4-quinolyl)-N-[di(lower alkyl)amino(loweralkyl)]-N-(lower alkyl)benzamides and their pharmaceutically acceptable acid addition salts exhibit interesting anti-inflammatory activity. They also exhibit anti-malarial activity and anti-hypertensive activity.

Abstract: The disclosure describes new 4-aminoquinoline derivatives of general formula ##SPC1##And their acid addition salts, where X is a halogen atom or a trifluoromethyl group, Z is a hydrogen atom or a defined substituent, R is group of the formula--R.sub.3 N--A--NR.sub.1 R.sub.2 (II), ##SPC2##where A in formula II is a chain of 1 to 5 methylene groups which may be substituted with alkyl, the ring in formula IIIa and IIIb is a piperidine or pyrrolidine ring that may be substituted with alkyl and R.sub.1, R.sub.2 and R.sub.3 represent hydrogen or certain defined substituents. The new 4-aminoquinoline derivatives show anti-malarial activity and, in some cases, show one or more of the following activities:- anti-inflammatory activity, anti-hypertensive activity, anti-trichomonal activity, inhibition of blood platelet aggregation, anti-ulcer activity and activity against allergic asthma.

Abstract: This invention relates to compounds having the formula: ##SPC1##And the pharmaceutically acceptable acid addition salts thereof, wherein R represents a phenyl or substituted phenyl radical in which said substituent is halogen, lower alkyl, lower alkoxy, nitro or trihalo lower alkyl; A represents a lower alkylene radical; and R.sup.1 and R.sup.2 independently represents hydrogen or lower alkyl; or R.sup.1 and R.sup.2 together with the nitrogen to which they are attached represent a heterocyclic ring selected from pyrrolidino, piperidino or morpholino; which inhibit blood platelet aggregation.

Abstract: 3-Phenyl substituted 1,2-benzisoxazole acetic and propionic acid derivatives with anti-inflammatory activity.

Abstract: The disclosure describes new 4-aminoquinoline derivatives of general formula ##SPC1##And their acid addition salts, where X is a halogen atom or a trifluoromethyl group, Z is a hydrogen atom or a defined substituent, R is group of the formula--R.sub.3 N--A--NR.sub.1 R.sub.2 (II)--nr.sub.1 n--r.sub.3 (iii a)Or--N N NR.sub.1 R.sub.2 (III b)where A in formula II is a chain of 1 to 5 methylene groups which may be substituted with alkyl, the ring in formula IIIa and IIIb is a piperidine or pyrrolidine ring that may be substituted with alkyl and R.sub.1, R.sub.2 and R.sub.3 represent hydrogen or certain defined substituents. The new 4-aminoquinoline derivatives show anti-hypertensive activity and, in some cases, show one or more of the following activities: anti-malarial activity, anti-inflammatory activity, anti-trichomonal activity and inhibition of blood platelet aggregation.